Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization

Publisher： Karger

E-ISSN： 1421-9832|232|1|7-8

ISSN： 1018-8665

Source： Dermatology, Vol.232, Iss.1, 2016-08, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis

By  

Dermatology, Vol. 232, Iss. 1, 2016-08 ,pp. : 4-6

Karger

Access to resources Recommend Favorite

Ingenol Mebutate Treatment in a Patient with Gorlin Syndrome

By  

Dermatology, Vol. 232, Iss. 1, 2016-08 ,pp. : 29-31

Karger

Access to resources Recommend Favorite

A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp

By  

Dermatology, Vol. 232, Iss. 4, 2016-08 ,pp. : 472-477

Karger

Access to resources Recommend Favorite

Successful Treatment of Relapsing Bowen's Disease with Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response

By  

Dermatology, Vol. 232, Iss. 1, 2016-08 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

Ingenol Mebutate 150 mg as Physician-Directed Treatment of Bowen's Disease Under Occlusion

By  

Dermatology, Vol. 232, Iss. 1, 2016-08 ,pp. : 17-19

Karger

Access to resources Recommend Favorite